Artemis Medicare Services Ltd

₹ 252 -0.34%

11 Jul - close price

artemishospitals.com BSE: 542919 NSE: ARTEMISMED

About

Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. The specialty areas for AMSL include Orthopaedics, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. ASML has been awarded with the NABH and JCI accreditation. AMSL has also diversified its presence through Artemis Daffodil , Artemis Lite, Artemis Cardiac Care and Artemis Solace models. ^[1]^[2]

Key Points

Geographical Revenue Break-up 9MFY24:^[1]
Domestic : ~76%
Outside India : ~24%

Website BSE NSE

Market Cap ₹ 3,496 Cr.
Current Price ₹ 252
High / Low ₹ 350 / 200
Stock P/E 41.8
Book Value ₹ 61.2
Dividend Yield 0.18 %
ROCE 14.9 %
ROE 12.9 %
Face Value ₹ 1.00

Add ratio to table

Edit ratios

Pros

Company has delivered good profit growth of 32.5% CAGR over last 5 years

Cons

Stock is trading at 4.11 times its book value
Company has a low return on equity of 11.7% over last 3 years.
Promoters have pledged or encumbered 44.5% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	146	163	182	181	187	201	217	210	217	217	235	227	235
	129	144	158	156	163	174	184	179	181	181	193	190	199
Operating Profit	17	19	24	26	25	27	33	32	36	36	42	37	36
OPM %	12%	12%	13%	14%	13%	14%	15%	15%	17%	16%	18%	16%	15%
	1	2	1	1	2	1	2	2	2	4	8	9	12
Interest	4	4	5	5	5	6	7	8	8	8	8	8	8
Depreciation	6	6	7	8	8	9	9	10	10	10	11	11	11
Profit before tax	8	11	14	14	14	13	19	16	19	22	31	27	29
Tax %	-57%	22%	31%	23%	23%	26%	27%	29%	28%	24%	27%	23%	20%
	13	9	10	11	10	10	14	12	14	17	23	21	23
EPS in Rs	1.01	0.65	0.73	0.80	0.78	0.73	1.01	0.85	1.02	1.24	1.64	1.51	1.69
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	261	368	402	459	503	547	563	402	545	714	845	913
	234	325	359	406	442	480	501	367	477	620	717	763
Operating Profit	27	43	43	53	60	66	62	35	68	94	128	150
OPM %	11%	12%	11%	11%	12%	12%	11%	9%	12%	13%	15%	16%
	1	3	5	4	3	2	4	7	3	7	7	33
Interest	13	12	9	9	9	11	13	12	11	19	30	30
Depreciation	9	12	12	15	18	20	22	21	21	29	38	43
Profit before tax	7	21	27	32	35	37	32	9	39	53	68	109
Tax %	0%	12%	21%	16%	24%	44%	36%	20%	16%	25%	28%	24%
	7	19	22	27	27	21	20	7	33	40	49	83
EPS in Rs	0.32	0.88	1.03	1.29	1.27	0.98	1.54	0.54	2.46	2.96	3.62	6.07
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	15%	12%	7%

Compounded Sales Growth
10 Years:	10%
5 Years:	10%
3 Years:	19%
TTM:	8%

Compounded Profit Growth
10 Years:	16%
5 Years:	32%
3 Years:	36%
TTM:	71%

Stock Price CAGR
10 Years:	%
5 Years:	69%
3 Years:	73%
1 Year:	16%

Return on Equity
10 Years:	10%
5 Years:	10%
3 Years:	12%
Last Year:	13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	21	21	21	21	21	0.00	13	13	13	13	14	14
Reserves	116	135	163	183	210	280	301	308	348	393	438	828
	110	85	68	94	91	114	108	137	190	268	305	280
	66	90	93	124	130	160	159	130	145	207	191	221
Total Liabilities	313	331	345	422	452	555	581	589	697	882	948	1,343
	236	239	249	283	309	381	387	372	476	584	699	729
CWIP	0	0	1	27	43	49	56	81	64	95	33	40
Investments	0	0	0	0	0	0	2	4	6	12	15	15
	77	91	94	112	100	124	137	132	152	192	200	559
Total Assets	313	331	345	422	452	555	581	589	697	882	948	1,343

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	45	53	20	58	72	41	56	27	61	129	108	139
	-12	-10	-14	-74	-67	-50	-22	-34	-106	-153	-90	-388
	-21	-35	-24	19	-10	14	-33	13	44	30	-26	277
Net Cash Flow	11	7	-18	3	-4	5	2	6	-2	7	-8	28

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	41	39	49	48	40	52	50	48	47	43	36	37
Inventory Days	26	26	21	19
Days Payable	237	195	189	187
Cash Conversion Cycle	-171	-129	-120	-120	40	52	50	48	47	43	36	37
Working Capital Days	-70	-59	-31	-44	-53	-26	-28	-15	-10	-29	-17	-15
ROCE %	8%	14%	15%	16%	15%	14%	11%	4%	10%	11%	14%	15%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	69.59%	69.27%	68.91%	68.91%	68.03%	68.03%	68.03%	68.03%	67.51%	67.17%	67.17%	67.17%
	0.00%	0.00%	0.00%	0.00%	0.07%	0.09%	0.11%	0.10%	0.16%	0.21%	0.65%	0.31%
	0.91%	0.90%	1.15%	1.37%	1.41%	1.51%	1.96%	2.61%	3.45%	3.60%	4.51%	5.04%
	7.34%	7.31%	7.27%	7.27%	7.18%	7.18%	7.18%	7.18%	7.12%	7.09%	7.09%	7.09%
	22.17%	22.53%	22.65%	22.43%	23.30%	23.18%	22.72%	22.08%	21.76%	21.93%	20.59%	20.39%
No. of Shareholders	15,177	14,637	17,995	18,100	19,082	20,529	22,375	19,993	19,795	26,054	27,004	28,397

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	69.82%	69.82%	69.82%	68.91%	68.03%	67.17%
	0.00%	0.00%	0.00%	0.00%	0.10%	0.31%
	1.22%	1.22%	1.10%	1.37%	2.61%	5.04%
	7.37%	7.37%	7.37%	7.27%	7.18%	7.09%
	21.59%	21.59%	21.71%	22.43%	22.08%	20.39%
No. of Shareholders	5,590	5,273	12,098	18,100	19,993	28,397

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

May 2025

Transcript

Notes
PPT
Feb 2025

Transcript

Notes
PPT
Nov 2024

Transcript

Notes
PPT
Aug 2024

Transcript

Notes
PPT
May 2024

Transcript

Notes
PPT
Feb 2024

Transcript

Notes
PPT
Feb 2024

Transcript

Notes
PPT
Nov 2023

Transcript

Notes
PPT
Aug 2023

Transcript

Notes
PPT
May 2023

Transcript

Notes
PPT
Feb 2023

Transcript

Notes
PPT
Nov 2022

Transcript

Notes
PPT